OCWP
MRVI icon

Owl Creek Wealth Partners’s Maravai LifeSciences MRVI Stock Holding History

Owl Creek Wealth Partners’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.87K Hold
780
– – ﹤0.01% 1021
2026
Q1 		$2.21K Buy
+780
New +$2.64K ﹤0.01% 1104

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OAM
Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Owl Creek Wealth Partners's MRVI Position: Q2 2026 in Review

Owl Creek Wealth Partners held its Maravai LifeSciences (MRVI) position steady in Q2 2026 at 780 shares worth $4.87K. The position accounts for ﹤0.01% of the portfolio, ranked #1021.

Owl Creek Wealth Partners first reported a position in MRVI in Q1 2026 and has held it in 2 quarters since. 162 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

  • Owl Creek Wealth Partners held 780 shares of Maravai LifeSciences worth $4.87K as of Q2 2026.
  • Owl Creek Wealth Partners left its Maravai LifeSciences share count unchanged in Q2 2026.
  • Maravai LifeSciences made up ﹤0.01% of Owl Creek Wealth Partners's portfolio in Q2 2026, its #1021 holding.
  • Owl Creek Wealth Partners first reported a position in Maravai LifeSciences in Q1 2026 and has held it in 2 quarters since.
  • 162 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on Owl Creek Wealth Partners's 13F filing for Q2 2026, filed 20 Jul 2026.